MorphoSys (MOR) Stock Forecast & Price Target

€20.00

+0.75 (+3.90%)

(As of 11/29/2023 ET)

Compare

Today's Range: €19.14
▼
€20.00
50-Day Range: €16.09
▼
€31.56
52-Week Range: €11.81
▼
€32.49

Volume: 540,555 shs
Average Volume: 153,687 shs
Market Capitalization: $683.40 million

P/E Ratio: 7.46
Dividend Yield: 1.26%
Price Target: €11.83

Stock Analysis Analyst Forecasts Chart Headlines

MorphoSys Consensus Analyst Rating and Stock Price Forecast (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

N/A
Based on 0 Analyst Ratings

Analysts' Consensus Price Target

€11.83

High Forecast	€12.50
Average Forecast	€11.83
Low Forecast	€11.00

Type	Current Forecast 11/30/22 to 11/30/23	1 Month Ago 10/31/22 to 10/31/23	3 Months Ago 9/1/22 to 9/1/23	1 Year Ago 11/30/21 to 11/30/22
Consensus Rating	N/A	N/A	N/A	N/A
Strong Buy	N/A	N/A	N/A	N/A
Buy	N/A	N/A	N/A	N/A
Hold	N/A	N/A	N/A	N/A
Sell	N/A	N/A	N/A	N/A
Consensus Price Target	€11.83	€12.13	€12.13	€31.20

Get MorphoSys Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for MOR and its competitors with MarketBeat's FREE daily newsletter.

MOR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

MOR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

MorphoSys Stock vs. The Competition

Type	MorphoSys	Medical Companies
Consensus Rating Score	0.00	2.67
Consensus Rating	N/A	Moderate Buy
News Sentiment Rating	Positive News	Positive News

Recent Analyst Ratings and Stock Forecasts

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Price Target	Upside/Downside on Report Date
3/16/2023	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Gordon Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target	€11.00	-19.33%
1/6/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	James Quigley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target	€12.50	-7.68%
1/3/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Rajan Sharma Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Target	€12.00	-11.50%

(Data available from 11/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

MOR Price Target - Frequently Asked Questions

Does MorphoSys's stock price have much downside?: According to analysts, MorphoSys's stock has a predicted downside of -12.85% based on their 12-month stock forecasts.

Stock Ratings Reports and Tools

Related Companies:

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

This page (ETR:MOR) was last updated on 11/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial